Industry Group Chat at GCSG US
GCSG US highlighted a Clinical Trial Services landscape focused on operational transformation, stronger collaboration models, and a renewed emphasis on patient-centric execution. Conversations throughout the event reflected an industry moving beyond traditional processes and embracing more dynamic, connected approaches to trial management, compliance, and clinical supply strategy.
Representing Tanner Pharma Group’s Clinical Trial Solutions team on site, Lisa Fotheringham and Ciara O’Leary engaged with sponsors, CROs, and service providers to explore the trends shaping the future of clinical trial operations. Discussions centered on how organizations are adapting to increasing complexity while seeking greater efficiency, flexibility, and alignment across global trial ecosystems.
This recap captures the key themes emerging from those conversations, including the evolution of pharmacy manuals from static documentation into dynamic tools that support execution and compliance, the growing prioritization of patient-centricity as an operational imperative, and the increasing importance of strategic sponsor-vendor partnerships in areas such as comparator sourcing and clinical supply management.
Attendees also highlighted the mounting complexity associated with packaging, labeling, and investigator-sponsored trials, driving demand for more coordinated planning and execution models. At the same time, advances in automation and integrated content management are reshaping how organizations approach clinical labeling, helping teams improve consistency, reduce risk, and maintain compliance across global studies.
Across every conversation, one message was clear: the CTS industry has significant momentum. Organizations that can effectively align people, processes, and technology while fostering stronger collaboration across stakeholders will be best positioned to navigate complexity and accelerate clinical development.
At Tanner Pharma Group, we help biopharmaceutical companies turn that momentum into measurable results through flexible Clinical Trial Solutions, global operational expertise, and collaborative delivery models that support successful trial execution from planning through completion.
